KATIE TETANICH: Open Payments
NPI 1568115343 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 51 payments from 19 companies in 2025. Trend: 2023 $1,277 · 2024 $1,123 · 2025 $1,184
Food & beverage: $1,184
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 10 | $244 |
| CORDIS US CORP. | 1 | $125 |
| Fresenius USA Marketing, Inc. | 6 | $108 |
| Otsuka America Pharmaceutical, Inc. | 3 | $85 |
| Apellis Pharmaceuticals, Inc. | 3 | $82 |
| Mallinckrodt Hospital Products Inc. | 3 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Travere Therapeutics, Inc. | 3 | $73 |
| Amgen Inc. | 4 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $62 |
Products named: TARPEYO, S.M.A.R.T. CONTROL, VELPHORO, JYNARQUE, TERLIVAZ, TAVNEOS, Kerendia, Empaveli.
Industry payments across SC — which companies pay providers there.
